345 related articles for article (PubMed ID: 28314223)
1. GV1001 immunotherapy ameliorates joint inflammation in a murine model of rheumatoid arthritis by modifying collagen-specific T-cell responses and downregulating antigen-presenting cells.
Choi IA; Choi JY; Jung S; Basri F; Park S; Lee EY
Int Immunopharmacol; 2017 May; 46():186-193. PubMed ID: 28314223
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis.
Li Y; Wu S; Li Y; Jiang S; Lin T; Xia L; Shen H; Lu J
Mol Biol Rep; 2016 Sep; 43(9):947-56. PubMed ID: 27379996
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of Oroxylin A in rheumatoid arthritis.
Wang YL; Gao JM; Xing LZ
Int Immunopharmacol; 2016 Nov; 40():294-299. PubMed ID: 27643663
[TBL] [Abstract][Full Text] [Related]
5. IL-35 ameliorates collagen-induced arthritis by promoting TNF-α-induced apoptosis of synovial fibroblasts and stimulating M2 macrophages polarization.
Peng M; Qiang L; Xu Y; Li C; Li T; Wang J
FEBS J; 2019 May; 286(10):1972-1985. PubMed ID: 30834683
[TBL] [Abstract][Full Text] [Related]
6. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis.
Gui H; Liu X; Liu LR; Su DF; Dai SM
Immunobiology; 2015 Jun; 220(6):817-22. PubMed ID: 25601571
[TBL] [Abstract][Full Text] [Related]
7. Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages.
Matsumoto T; Takahashi N; Kojima T; Yoshioka Y; Ishikawa J; Furukawa K; Ono K; Sawada M; Ishiguro N; Yamamoto A
Arthritis Res Ther; 2016 Jun; 18(1):133. PubMed ID: 27267914
[TBL] [Abstract][Full Text] [Related]
8. Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis.
Odobasic D; Jia Y; Kao W; Fan H; Wei X; Gu R; Ngo D; Kitching AR; Holdsworth SR; Morand EF; Yang YH
Int Immunopharmacol; 2018 Aug; 61():140-149. PubMed ID: 29879657
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression.
Neurath MF; Hildner K; Becker C; Schlaak JF; Barbulescu K; Germann T; Schmitt E; Schirmacher P; Haralambous S; Pasparakis M; Meyer Zum Büschenfelde KH; Kollias G; Märker-Hermann E
Clin Exp Immunol; 1999 Jan; 115(1):42-55. PubMed ID: 9933419
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-derived delta-like protein 1 enhances interleukin-6 and matrix metalloproteinase 3 production by fibroblast-like synoviocytes in mice with collagen-induced arthritis.
Sekine C; Nanki T; Yagita H
Arthritis Rheumatol; 2014 Oct; 66(10):2751-61. PubMed ID: 24943093
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-126 expression inhibits IL-23R mediated TNF-α or IFN-γ production in fibroblast-like synoviocytes in a mice model of collagen-induced rheumatoid arthritis.
Gao J; Kong R; Zhou X; Ji L; Zhang J; Zhao D
Apoptosis; 2018 Dec; 23(11-12):607-615. PubMed ID: 30167920
[TBL] [Abstract][Full Text] [Related]
12. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 antagonist NBI-74330 mitigates joint inflammation in Collagen-Induced arthritis model in DBA/1J mice.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alomar HA; Al-Mazroua HA; Ibrahim KE; Alshamrani AA; Al-Hamamah MA; Alfardan AS; Attia SM
Int Immunopharmacol; 2023 May; 118():110099. PubMed ID: 37018975
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
15. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
[TBL] [Abstract][Full Text] [Related]
16. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
17. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation.
Lee SY; Min HK; Lee SH; Shin HJ; Lee WY; Cho YG; Kwok SK; Ju JH; Cho ML; Park SH
Immunol Lett; 2016 Apr; 172():56-66. PubMed ID: 26903194
[TBL] [Abstract][Full Text] [Related]
18. Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis.
Zhang QG; Qian J; Zhu YC
Immunol Lett; 2015 Aug; 166(2):103-8. PubMed ID: 26093279
[TBL] [Abstract][Full Text] [Related]
19. A directly GP130-targeting small molecule ameliorates collagen-induced arthritis (CIA) by inhibiting IL-6/GP130 signalling and Th17 differentiation.
Park YH; Kim HJ; Heo TH
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):628-639. PubMed ID: 31742738
[TBL] [Abstract][Full Text] [Related]
20. Antiinflammatory properties of a peptide derived from interleukin-4.
Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
